Category:NilotinibNilotinibNilotinibNilotinib%D9%86%DB%8C%D9%84%D9%88%D8%AA%DB%8C%D9%86%DB%8C%D8%A8NilotinibiNilotinib%E3%83%8B%E3%83%AD%E3%83%81%E3%83%8B%E3%83%96NilotinibNilotynibNilotinibNilotinib%D0%9D%D1%96%D0%BB%D0%BE%D1%82%D0%B8%D0%BD%D1%96%D0%B1NilotinibQ412327%E5%B0%BC%E7%BD%97%E6%9B%BF%E5%B0%BC
about
P3781
Q27653851-A8E09DE6-014C-449E-8F53-AA8D17284D59Q28371006-15967E92-91B5-4D7C-BA9B-0921DABA6EECQ29938509-FC59EAFC-6843-4BD2-AAA4-910A58C199CDQ29938516-47170217-CD4E-47CC-AE5C-0DB10D67C8F8Q29938518-7B5BDFE8-464C-49AF-9C62-288975A6F932Q29938520-D5D0EC07-D6FD-4C73-BEDC-BC012542CEB0Q29938666-A77F4FE6-7096-4797-8491-765F00535E2BQ29938716-553256B2-3070-420C-AA22-CB401C5CBF01Q29938719-35664E39-5F4B-48CB-8F82-07A46BD8F13EQ38105235-3D38E0B2-1B39-433F-A4B7-EBD104AEE804Q38152931-839AECB9-427A-468D-93BF-CC0C9B4EC6E1Q38152933-D876E29D-99B2-446D-A58E-A8E402BB5E26Q38152934-0E5A1459-0E64-48A4-8185-66E062867ADD
P3354
description
Arzneistoff
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Nilotinib
@de
Nilotinib
@en-ca
Nilotinib
@en-gb
Nilotinib
@es
Nilotinib
@nl
Nilotinib
@sh
Nilotinib
@sr
Nilotinib
@vi
Nilotinibi
@fi
Nilotynib
@pl
type
label
Nilotinib
@de
Nilotinib
@en-ca
Nilotinib
@en-gb
Nilotinib
@es
Nilotinib
@nl
Nilotinib
@sh
Nilotinib
@sr
Nilotinib
@vi
Nilotinibi
@fi
Nilotynib
@pl
altLabel
AMN 107
@en
AMN107
@en
Nilotinib
@en
Nilotinibum
@en
Tasigna
@de
Tasigna
@nb
Tasigna®
@en
Тасигна
@uk
达希纳
@zh
prefLabel
Nilotinib
@de
Nilotinib
@en-ca
Nilotinib
@en-gb
Nilotinib
@es
Nilotinib
@nl
Nilotinib
@sh
Nilotinib
@sr
Nilotinib
@vi
Nilotinibi
@fi
Nilotynib
@pl